BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Insulin-like growth factor-1 receptor (IGF1R; CD221); survival of motor neuron 1 telomeric (SMN1)

September 24, 2015 7:00 AM UTC

Mouse studies suggest inhibiting IGF1R could help treat SMA. In a mouse model of SMA, spinal cord levels of IGF1R were higher than in spinal cords of normal mice. In the mouse model of SMA, heterozygo...